Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kimiharu Takamatsu
Observed names:
K. Takamatsu,
KIMIHARU TAKAMATSU,
Kimiharu Takamatsu*,
Takamatsu, Kimiharu
Institutions:
Saitama International Medical Center,
Saitama Medical University
Observed institutions:
Keio University,
Karolinska Institutet,
Keio University Hospital,
Saitama International Medical Center,
Nerima General Hospital,
Mita Hospital,
Saitama Medical University
show all 7
ORCID:
0000-0002-3325-6606
Observed ORCID:
0000-0002-3325-6606
OpenAlex ID:
A5063095736
Works
65
Awards
3
Whole-brain spatial transcriptional analysis at cellular resolution
2024
·
Shigeaki Kanatani
, Judith C. Kreutzmann
, et al.
·
Science
·
83
PDF
Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy
2021
·
Kimiharu Takamatsu
, Nobuyuki Tanaka
, et al.
·
Nature Communications
·
81
PDF
Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer
2022
·
Tsukasa Masuda
, Nobuyuki Tanaka
, et al.
·
Journal for ImmunoTherapy of Cancer
·
77
TNFAIP2 expression induces epithelial-to-mesenchymal transition and confers platinum resistance in urothelial cancer cells
2019
·
Naoya Niwa
, Nobuyuki Tanaka
, et al.
·
Laboratory Investigation
·
45
PDF
Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma
2021
·
Tetsushi Murakami
, Nobuyuki Tanaka
, et al.
·
Cancer Immunology Immunotherapy
·
40
The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy
2019
·
Kimiharu Takamatsu
, Kazuhiro Matsumoto
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
25
Prognostic Value of Baseline Serum C-Reactive Protein Level in Intermediate-Risk Group Patients With Metastatic Renal-Cell Carcinoma Treated by First-Line Vascular Endothelial Growth Factor–Targeted Therapy
2018
·
Kimiharu Takamatsu
, Ryuichi Mizuno
, et al.
·
Clinical Genitourinary Cancer
·
24
Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer
2019
·
Kazuhiro Matsumoto
, Hirotaka Akita
, et al.
·
Prostate Cancer and Prostatic Diseases
·
23
Serum Lactate Dehydrogenase Before Nivolumab Treatment Could Be a Therapeutic Prognostic Biomarker for Patients With Metastatic Clear Cell Renal Cell Carcinoma
2019
·
SUGURU SHIROTAKE
, KIMIHARU TAKAMATSU
, et al.
·
Anticancer Research
·
21
PDF
Can urologists introduce the concept of “oligometastasis” for metastatic bladder cancer after total cystectomy?
2017
·
Koichiro Ogihara
, Eiji Kikuchi
, et al.
·
Oncotarget
·
20
Landscape of prognostic signatures and immunogenomics of the AXL/GAS6 axis in renal cell carcinoma
2021
·
Kyohei Hakozaki
, Nobuyuki Tanaka
, et al.
·
British Journal of Cancer
·
19
Grading of Multifocal Prostate Cancer Cases in which the Largest Volume and the Highest Grade Do Not Coincide within One Lesion
2021
·
Kazuhiro Matsumoto
, Minami Omura
, et al.
·
The Journal of Urology
·
14
Single-Cell Phenotyping of CD73 Expression Reveals the Diversity of the Tumor Immune Microenvironment and Reflects the Prognosis of Bladder Cancer
2023
·
Mizuki Izawa
, Nobuyuki Tanaka
, et al.
·
Laboratory Investigation
·
13
Role of Previous Malignancy History in Clinical Outcomes in Patients with Initially Diagnosed Non-Muscle Invasive Bladder Cancer
2021
·
Ryohei Kufukihara
, Eiji Kikuchi
, et al.
·
Annals of Surgical Oncology
·
8
Ureterosciatic Hernia Treated with Laparoscopic Intraperitonization of the Ureter
2020
·
Ken Kamisawa
, Takashi Ohigashi
, et al.
·
Journal of Endourology Case Reports
·
8
Accidental Hypothermia Treated by Hemodialysis in the Acute Phase: Three Case Reports and a Review of the Literature
2019
·
Tetsushi Murakami
, Tadashi Yoshida
, et al.
·
Internal Medicine
·
8
PDF
Hybridisation chain reaction-based visualisation and screening for lncRNA profiles in clear-cell renal-cell carcinoma
2022
·
Ryohei Kufukihara
, Nobuyuki Tanaka
, et al.
·
British Journal of Cancer
·
7
Appropriate timing for a biochemical evaluation after adrenalectomy for unilateral aldosterone‐producing adenoma
2020
·
Kimiharu Takamatsu
, Toshikazu Takeda
, et al.
·
Clinical Endocrinology
·
7
Increased Expression of AXL and c‐MET in High‐Grade Clear Cell Renal Cell Carcinoma and Its Association With VEGFR‐TKI Treatment and PD‐L1 Expression
2025
·
Shuji Mikami
, Ryuichi Mizuno
, et al.
·
Pathology International
·
6
PDF
Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients
2019
·
Kimiharu Takamatsu
, Ryuichi Mizuno
, et al.
·
International Journal of Clinical Oncology
·
6
Volumetric imaging of the tumor microvasculature reflects outcomes and genomic states of clear cell renal cell carcinoma
2024
·
Yuta Kaneko
, Tsukasa Masuda
, et al.
·
The Journal of Pathology Clinical Research
·
5
On-treatment C-reactive protein control could predict response to subsequent anti-PD-1 treatment in metastatic renal cell carcinoma
2021
·
Kimiharu Takamatsu
, Ryuichi Mizuno
, et al.
·
International Journal of Clinical Oncology
·
4
Impact of prostatic shape on the difficulty of robot‐assisted laparoscopic radical prostatectomy
2024
·
Ken Kamisawa
, Kazuhiro Matsumoto
, et al.
·
Asian Journal of Endoscopic Surgery
·
3
PDF
Uncovering LAG-3 related tumor immunology in renal cell carcinoma and pan-cancer evaluation.
2023
·
Kimiharu Takamatsu
, Nobuyuki Tanaka
, et al.
·
Journal of Clinical Oncology
·
3
Prognostic role of the innate immune signature CD163 and “eat me” signal calreticulin in clear cell renal cell carcinoma
2023
·
Tadatsugu Anno
, Nobuyuki Tanaka
, et al.
·
Cancer Immunology Immunotherapy
·
3
PDF
Show more works
View as search
Works count:
65
Citation count:
570
H-index:
13
I10-index:
13
Year
Topic
Type